Nanotechnology: To Know It Is Not Necessarily To Love It

Navigate to:

Nanotechnology: To Know It Is Not Necessarily To Love It

Public opinion surveys report that the small fraction of people who know about nanotechnology have a favorable view of it. This finding has led many to assume that the public at large will respond favorably to nanotechnology applications as popular awareness grows, education expands and commercialization increases.

But the results of an experiment, conducted by the Cultural Cognition Project at Yale Law School in collaboration with the Project on Emerging Nanotechnologies (PEN) and published Dec. 7 on the Nature Nanotechnology Web site, do not support this "familiarity hypothesis."

The experiment found that how people react to information about nanotechnology depends on cultural predispositions. Exposed to balanced information, people with pro-commerce values tend to see the benefits of nanotechnology as outweighing any risks. However, people with egalitarian or communitarian values who are predisposed to blame commerce and industry for social inequities and environmental harm tend to see nanotechnology risks as outweighing benefits.

The study also found that people who have pro-commerce cultural values are more likely to know about nanotechnology than others. "Not surprisingly, people who are enthused by technology and believe it can be safe and beneficial tend to learn about new technologies before other people do," said Dan Kahan, Professor at Yale Law School and lead author of the Nature Nanotechnology article. "So while various opinion polls suggest that familiarity with nanotechnology leads people to believe it is safe, they have been confusing cause with effect."

The findings of the experiment highlight the need for any nanotechnology information and risk communication strategy to focus on message framing and to take an informed, multi-audience approach, according to PEN experts.

"The message matters. How information about nanotechnology is presented to the vast majority of the public who still know little about it can either make or break this technology," says David Rejeski, the director of PEN. "Scientists, the government and industry generally take a simplistic, 'just the facts' approach to communicating with the public about a new technology. But this research shows that diverse audiences and groups react to the same information very differently."

Because perfecting the science of nanotechnology risk communication is essential to society's realization of the full benefits of nanotechnology itself, PEN experts believe that every major funding initiative directed at the development of nanotechnology and the study of nanotechnology risks should include a risk-communication component.

"Without investment in understanding how to explain the potential risks, as well as the potential benefits, to the public, significant innovation could be stifled," Rejeski adds.

The study was conducted as part of a series of public opinion analyses being conducted jointly by the Cultural Cognition Project and the Project on Emerging Nanotechnologies.

Pew is no longer active in this line of work, but for more information, visit the Project on Emerging Nanotechnologies on PewHealth.org.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.